» Articles » PMID: 35224148

Tumor Microenvironment Pathways: Cross Regulation in Breast Cancer Metastasis

Overview
Journal Genes Dis
Date 2022 Feb 28
PMID 35224148
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment (TME) is heterogeneous and contains a multiple cell population with surrounded immune cells, which plays a major role in regulating metastasis. The multifunctional pathways, Hedgehog (Hh), Wnt, Notch, and NF-kB, cross-regulates metastasis in breast cancer. This review presents substantial evidence for cross-regulation of TME components and signaling pathways, which makes breast TME more heterogeneous and complex, promoting breast cancer progression and metastasis as a highly aggressive form. We discoursed the importance of stromal and immune cells as well as their crosstalk in bridging the metastasis. We also discussed the role of Hh and Notch pathways in the intervention between breast cancer cells and macrophages to support TME; Notch signaling in the bidirectional communication between cancer cells and components of TME; Wnt signal pathway in controlling the factors responsible for EMT and NF-κB pathway in the regulation of genes controlling the inflammatory response. We also present the role of exosomes and their miRNAs in the cross-regulation of TME cells as well as pathways in the reprogramming of breast TME to support metastasis. Finally, we examined and discussed the targeted small molecule inhibitors and natural compounds targeting developmental pathways and proposed small molecule natural compounds as potential therapeutics of TME based on the multitargeting ability. In conclusion, the understanding of the molecular basis of the cross-regulation of TME pathways and their inhibitors helps identify molecular targets for rational drug discovery to treat breast cancers.

Citing Articles

Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer.

Dong R, Wang J, Guan R, Sun J, Jin P, Shen J Antioxidants (Basel). 2025; 14(1).

PMID: 39857438 PMC: 11760893. DOI: 10.3390/antiox14010104.


H1 Antihistamines-Promising Candidates for Repurposing in the Context of the Development of New Therapeutic Approaches to Cancer Treatment.

Trybus E, Trybus W Cancers (Basel). 2025; 16(24.

PMID: 39766152 PMC: 11674717. DOI: 10.3390/cancers16244253.


Coptisine enhances the sensitivity of chemoresistant breast cancer cells by inhibiting the function and expression of ABC transporters.

Eid S Front Pharmacol. 2024; 15:1472458.

PMID: 39691399 PMC: 11650208. DOI: 10.3389/fphar.2024.1472458.


The development of the occurrence and metastasis of breast cancer by single-cell sequencing.

Chen M, Feng M, Lei H, Mo D, Ren S, Yang D Cancer Cell Int. 2024; 24(1):349.

PMID: 39462368 PMC: 11515250. DOI: 10.1186/s12935-024-03531-x.


Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).

Li H, Li X, Du W Oncol Rep. 2024; 52(2).

PMID: 38940326 PMC: 11234250. DOI: 10.3892/or.2024.8766.


References
1.
Nagase T, Nagase M, Machida M, Fujita T . Hedgehog signalling in vascular development. Angiogenesis. 2008; 11(1):71-7. DOI: 10.1007/s10456-008-9105-5. View

2.
Haikarainen T, Krauss S, Lehtio L . Tankyrases: structure, function and therapeutic implications in cancer. Curr Pharm Des. 2014; 20(41):6472-88. PMC: 4262938. DOI: 10.2174/1381612820666140630101525. View

3.
Varghese E, Samuel S, Abotaleb M, Cheema S, Mamtani R, Busselberg D . The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers. Cancers (Basel). 2018; 10(10). PMC: 6209965. DOI: 10.3390/cancers10100346. View

4.
Martins D, Schmitt F . Microenvironment in breast tumorigenesis: Friend or foe?. Histol Histopathol. 2018; 34(1):13-24. DOI: 10.14670/HH-18-021. View

5.
Fan P, Fan S, Wang H, Mao J, Shi Y, Ibrahim M . Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway. Stem Cell Res Ther. 2013; 4(6):146. PMC: 4054948. DOI: 10.1186/scrt357. View